InvestorsHub Logo

Tails

04/23/14 3:54 PM

#58803 RE: cabel #58796

Leo indicated that he was considering doing those tests at the conclusion of the current cohort. It is my understanding that no tests have been done on any cohorts since the initial testing.
This was revealed in an email exchange with dmattingly… post 52023

So, hopefully we will have those results before the end of July.

Go CTIX

dmattingly62 Monday, 01/20/14 10:53:09 PM
Re: None
Post # of 58802
Leo answered 3 questions -

1) Will there be an ASCO presentation this year on Kevetrin? Brilicidin OM?

Of course!

2) Why haven't we had an update on p21? When will we?

The tests are expensive and we were waiting for these higher patient doses. I cant give you an exact date but i am now planning to do such probably after this cohort.

3) Will you attempt to parter Brilicidin before a 2b readout?

Not for ABSSSI. For other indications where there is significant upfront costs we would look to do such as soon as more data from the phase 2 trial is available.